Last 12 months
Inside the activity.
21 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 11 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 8 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2017 Filed Aug 29, 2017 15:36 UTC |
Fishman KalmanChief Technology Officer
|
SaleCommon Stock | 4,501 | $6.00 | $27,006.00 |
DisclosureSEC source: 0001615774-17-004832 · s107374_form4.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 983,583 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.02. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 15:34 UTC |
Cohen Stephen BradExecutive Vice President
|
SaleCommon Stock | 2,617 | $6.00 | $15,702.00 |
DisclosureSEC source: 0001615774-17-004828 · s107372_form4.xml · nonDerivative · entry 1 Cohen Stephen Brad · CIK 0001670284 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 983,583 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.02. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 15:35 UTC |
Golin RichardExecutive Vice President
|
SaleCommon Stock | 4,501 | $6.00 | $27,006.00 |
DisclosureSEC source: 0001615774-17-004830 · s107373_form4.xml · nonDerivative · entry 1 Golin Richard · CIK 0001670070 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 983,583 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.02. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 19:32 UTC |
Sardano Joseph CDirector · Chief Executive Officer
|
SaleCommon Stock | 7,482 | $6.00 | $44,892.00 |
DisclosureSEC source: 0001615774-17-004826 · s107371_form4.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,625,821 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.02. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 19:30 UTC |
Levine ArthurChief Financial Officer
|
SaleCommon Stock | 235 | $6.00 | $1,410.00 |
DisclosureSEC source: 0001615774-17-004824 · s107370_form4.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,985 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.02. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| August 24, 2017 Filed Aug 25, 2017 14:46 UTC |
Fishman KalmanChief Technology Officer
|
SaleCommon Stock | 2,761 | $6.00 | $16,566.00 |
DisclosureSEC source: 0001615774-17-004747 · s107339_form4.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 988,084 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| August 24, 2017 Filed Aug 25, 2017 14:47 UTC |
Cohen Stephen BradExecutive Vice President
|
SaleCommon Stock | 2,761 | $6.00 | $16,566.00 |
DisclosureSEC source: 0001615774-17-004748 · s107340_form4.xml · nonDerivative · entry 2 Cohen Stephen Brad · CIK 0001670284 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 988,084 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| August 24, 2017 Filed Aug 25, 2017 14:47 UTC |
Golin RichardExecutive Vice President
|
SaleCommon Stock | 2,761 | $6.00 | $16,566.00 |
DisclosureSEC source: 0001615774-17-004749 · s107341_form4.xml · nonDerivative · entry 2 Golin Richard · CIK 0001670070 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 988,084 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| August 24, 2017 Filed Aug 25, 2017 18:48 UTC |
Sardano Joseph CDirector · Chief Executive Officer
|
SaleCommon Stock | 4,588 | $6.00 | $27,528.00 |
DisclosureSEC source: 0001615774-17-004750 · s107342_form4.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,633,303 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| August 24, 2017 Filed Aug 25, 2017 18:46 UTC |
Levine ArthurChief Financial Officer
|
SaleCommon Stock | 271 | $6.00 | $1,626.00 |
DisclosureSEC source: 0001615774-17-004746 · s107338_form4.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,220 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 14:46 UTC |
Fishman KalmanChief Technology Officer
|
SaleCommon Stock | 2,617 | $6.00 | $15,702.00 |
DisclosureSEC source: 0001615774-17-004747 · s107339_form4.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990,845 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 14:47 UTC |
Cohen Stephen BradExecutive Vice President
|
SaleCommon Stock | 2,617 | $6.00 | $15,702.00 |
DisclosureSEC source: 0001615774-17-004748 · s107340_form4.xml · nonDerivative · entry 1 Cohen Stephen Brad · CIK 0001670284 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990,845 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 14:47 UTC |
Golin RichardExecutive Vice President
|
SaleCommon Stock | 2,617 | $6.00 | $15,702.00 |
DisclosureSEC source: 0001615774-17-004749 · s107341_form4.xml · nonDerivative · entry 1 Golin Richard · CIK 0001670070 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990,845 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 18:48 UTC |
Sardano Joseph CDirector · Chief Executive Officer
|
SaleCommon Stock | 3,579 | $6.00 | $21,474.00 |
DisclosureSEC source: 0001615774-17-004750 · s107342_form4.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,637,891 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| June 02, 2017 Filed Jun 12, 2017 14:15 UTC |
Levine ArthurChief Financial Officer
|
Tax withholdingCommon Stock | 24,420 | $4.00 | $97,680.00 |
DisclosureSEC source: 0001615774-17-003098 · s106522_form4.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,491 F1 · security: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:49 UTC |
Levine ArthurChief Financial Officer
|
Tax withholdingCommon Stock | 29,003 | $4.99 | $144,724.97 |
DisclosureSEC source: 0001615774-17-000326 · form4levin.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,911 F1 · security: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. Read SEC document |
| January 20, 2017 Filed Jan 24, 2017 21:18 UTC |
Levine ArthurChief Financial Officer
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-17-000229 · levine.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,914 F1 · shares: Represents 10,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2016 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| December 02, 2016 Filed Dec 5, 2016 18:28 UTC |
Cohen Stephen BradExecutive Vice President
|
SaleCommon Stock | 123 | $6.00 | $738.00 |
DisclosureSEC source: 0001615774-16-008726 · s104871_form4.xml · nonDerivative · entry 2 Cohen Stephen Brad · CIK 0001670284 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 993,463 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| December 02, 2016 Filed Dec 5, 2016 18:31 UTC |
Fishman KalmanChief Technology Officer
|
SaleCommon Stock | 123 | $6.00 | $738.00 |
DisclosureSEC source: 0001615774-16-008728 · s104872_form4.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 993,463 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| December 02, 2016 Filed Dec 5, 2016 18:27 UTC |
Golin RichardExecutive Vice President
|
SaleCommon Stock | 123 | $6.00 | $738.00 |
DisclosureSEC source: 0001615774-16-008724 · s104870_golin.xml · nonDerivative · entry 2 Golin Richard · CIK 0001670070 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 993,463 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| December 02, 2016 Filed Dec 5, 2016 23:23 UTC |
Sardano Joseph CDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 166 | $6.00 | $996.00 |
DisclosureSEC source: 0001615774-16-008722 · s104869_sardano.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,641,470 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 18:28 UTC |
Cohen Stephen BradExecutive Vice President
|
SaleCommon Stock | 64 | $6.00 | $384.00 |
DisclosureSEC source: 0001615774-16-008726 · s104871_form4.xml · nonDerivative · entry 1 Cohen Stephen Brad · CIK 0001670284 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 993,586 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 18:31 UTC |
Fishman KalmanChief Technology Officer
|
SaleCommon Stock | 64 | $6.00 | $384.00 |
DisclosureSEC source: 0001615774-16-008728 · s104872_form4.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 993,586 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 18:27 UTC |
Golin RichardExecutive Vice President
|
SaleCommon Stock | 64 | $6.00 | $384.00 |
DisclosureSEC source: 0001615774-16-008724 · s104870_golin.xml · nonDerivative · entry 1 Golin Richard · CIK 0001670070 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 993,586 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 23:23 UTC |
Sardano Joseph CDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 108 | $6.00 | $648.00 |
DisclosureSEC source: 0001615774-16-008722 · s104869_sardano.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,641,636 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 18:01 UTC |
Fishman KalmanChief Technology Officer
|
SaleCommon Stock | 382 | $6.00 | $2,292.00 |
DisclosureSEC source: 0001615774-16-008661 · s104831_form4.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 993,650 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 18:03 UTC |
Cohen Stephen BradExecutive Vice President
|
SaleCommon Stock | 382 | $6.00 | $2,292.00 |
DisclosureSEC source: 0001615774-16-008663 · s104832_form4.xml · nonDerivative · entry 2 Cohen Stephen Brad · CIK 0001670284 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 993,650 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 18:05 UTC |
Golin RichardExecutive Vice President
|
SaleCommon Stock | 382 | $6.00 | $2,292.00 |
DisclosureSEC source: 0001615774-16-008665 · s104833_form4.xml · nonDerivative · entry 2 Golin Richard · CIK 0001670070 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 993,650 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 23:06 UTC |
Sardano Joseph CDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 520 | $6.00 | $3,120.00 |
DisclosureSEC source: 0001615774-16-008667 · s104834_form4.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,641,744 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| November 29, 2016 Filed Dec 1, 2016 18:01 UTC |
Fishman KalmanChief Technology Officer
|
SaleCommon Stock | 297 | $6.00 | $1,782.00 |
DisclosureSEC source: 0001615774-16-008661 · s104831_form4.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 994,032 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| November 29, 2016 Filed Dec 1, 2016 18:03 UTC |
Cohen Stephen BradExecutive Vice President
|
SaleCommon Stock | 297 | $6.00 | $1,782.00 |
DisclosureSEC source: 0001615774-16-008663 · s104832_form4.xml · nonDerivative · entry 1 Cohen Stephen Brad · CIK 0001670284 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 994,032 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| November 29, 2016 Filed Dec 1, 2016 18:05 UTC |
Golin RichardExecutive Vice President
|
SaleCommon Stock | 297 | $6.00 | $1,782.00 |
DisclosureSEC source: 0001615774-16-008665 · s104833_form4.xml · nonDerivative · entry 1 Golin Richard · CIK 0001670070 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 994,032 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| November 29, 2016 Filed Dec 1, 2016 23:06 UTC |
Sardano Joseph CDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 404 | $6.00 | $2,424.00 |
DisclosureSEC source: 0001615774-16-008667 · s104834_form4.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,642,264 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.